Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp

Comparative in-vitro activity of levofloxacin against Chlamydia spp.

one strain each and by trimethoprim for three strains were reduced (by 2, 6 and 6–7 mm, respectively) after incubation in a CO 2-containing atmosphere compared with those obtained following incubation in the aerobic atmosphere. None of the seven isolates was CO2dependent and in all cases, the susceptibility categories for the relevant antibiotics were downgraded from susceptible in the aerobic ...

Comparative in vitro activity of garenoxacin against Cfdamydkz spp

In vitro activity of fidaxomicin (OPT-80) tested against contemporary clinical isolates of Staphylococcus spp. and Enterococcus spp.

Fidaxomicin (formerly OPT-80) is a narrow-spectrum investigational, nonabsorbed oral agent being developed for the treatment of Clostridium difficile infection (CDI), which is not uncommon among hospitalized patients, resulting in longer hospital stays and increased medical care costs and mortality (2, 6, 7, 9–13, 15, 16). Current CDI therapies are compromised by high recurrence rates and risk ...

Comparative in vitro antimicrobial activity of tigecycline against clinical isolates of vancomycin-resistant enterococcus.

In vitro activity of Amazon plant extracts against Enterococcus faecalis

Previous studies analyzing 2,200 plant extracts indicated anti-enterococcal activity in 25 extracts obtained from Brazilian forests' plants. In the present study, these extracts were subjected to microdilution broth assay (MDBA) and disk diffusion assay (DDA) using planktonic Enterococcus faecalis ATCC(®) 29212™ and were submitted to phytochemical analysis in TLC and HPLC. Three extracts obtain...